for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

There are many new treatment options for the overactive bladder that are discussed in this article, including the recently introduced drugs tolterodine and oxybutynin XL. Other drugs are in ...

But now, Namazzi has been seeing patients where the drug takes several days to work. She wanted to understand what was going on. So she teamed up with others to figure it out. They had several ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

It is clearly effective in increasing bladder capacity, but the impacts on bedwetting are less certain with mixed results in research studies. It might be a useful adjunctive therapy to other ...

Apr. 30, 2024 — A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found ...

A clinical trial of the targeted drug revumenib in relapsed/refractory NMP1-mutant acute myelogenous leukemia met the primary endpoint of complete remission plus complete remission with partial ...

After hours: November 15 at 7:55 PM EST Loading Chart for DRUG ...